Eric Lefkofsky Tempus Lab Would Improve Patient Outcomes
For three years now, Eric Lefkofsky’s Tempus Incorporation has strived to improve the treatment and management of cancer and tumors. The company manages a library of molecular information used by oncologists to make critical medical resolutions. Into the bargain, Tempus cooperates with medical specialists develops genomic tests, image recognition algorithms, and other analytic tools used in the diagnosis and management of tumors.
Despite these endeavors, doctors complained that accessing Tempus platform using a computer was challenging and inconveniencing. They wanted a platform which they could obtain from their mobile devices. As a solution, Tempus’ software engineers developed Tempus Labs, an application that allows the doctors to access Tempus platform using modern mobile phones from any location.
Using the application, doctors can extract every bit of information stored in Tempus Incorporation’s library. They can retrieve patient reports, potential therapies that can be used to manage a patient’s unique case, relevant clinical trials, and any other relevant information that can be used to improve patient outcomes.
Doctors who need the app can download it from major app stores like Google Play. Alternatively, they can order Tempus’ xT, xE, or xO assays to get the application as an offer. While launching the new application, Tempus’ chief operating officer said that they were planning to expand their precision medicine solutions to other medical areas like neurology and cardiology.
According to the COO, Tempus Incorporation had enough resources to diversify their services. A Glance at Tempus Incorporation’s co-founder. Eric Lefkofsky co-founded Tempus Incorporation with the aim of improving the quality of healthcare accorded to patients living with cancer and other tumors. On that account, Lefkofsky and his partners agreed to focus on analyzing and storing vital scientific statistics that could be used to create real-time medical verdicts.
In less than three years, the company has grown to be one of the leading libraries of molecular data. Who is Eric Lefkofsky? Lefkofsky is a US-based businessperson, and philanthropist. Before establishing Tempus, he founded and managed several companies operating in US’ financial, healthcare, Logistics, and investment sectors. As a philanthropist, Mr. Lefkofsky operates a charity foundation that supports high-impact causes in the education, healthcare, human rights, and commercial industries.